Lavendamycin
Code | Size | Price |
---|
TAR-T25642-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25642-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Lavendamycin is a naturally occurring chemical isolated from fermentation broth of the soil bacterium Streptomyces lavendulae. It has antibiotic properties and significant anti-proliferative effects against several cancer cell lines.
CAS:
81645-09-2
Molecular Weight:
398.37
Purity:
0.98
SMILES:
O=C(O)C1=NC(C=2N=C3C(=O)C(N)=CC(=O)C3=CC2)=C4NC=5C=CC=CC5C4=C1C
References
Ramesh S, Nagarajan R. A formal synthesis of lavendamycin methyl ester, nitramarine, and their analogues: a Povarov approach. J Org Chem. 2013 Jan 18;78(2):545-58. doi: 10.1021/jo302389s. Epub 2012 Dec 20. PubMed PMID: 23215629.
McElroy WT, DeShong P. Siloxane-based cross-coupling of bromopyridine derivatives: studies for the synthesis of streptonigrin and lavendamycin. Org Lett. 2003 Dec 11;5(25):4779-82. PubMed PMID: 14653672.
Boger DL, Yasuda M, Mitscher LA, Drake SD, Kitos PA, Thompson SC. Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones. J Med Chem. 1987 Oct;30(10):1918-28. PubMed PMID: 3656364.
Xia X, Lin S, Xia XX, Cong FS, Zhong JJ. Significance of agitation-induced shear stress on mycelium morphology and lavendamycin production by engineered Streptomyces flocculus. Appl Microbiol Biotechnol. 2014 May;98(10):4399-407. doi: 10.1007/s00253-014-5555-4. Epub 2014 Feb 13. PubMed PMID: 24522728.